Lixte Biotechnology Holdings Overview
- Founded
- 2005
- Status
- Public
- Employees
- 4
- Stock Symbol
- LIXT
- Investments
- 1
- Share Price
- $1.36
- (As of Monday Closing)
Lixte Biotechnology Holdings General Information
Description
Lixte Biotech Holdings Inc is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. The company focuses on developing new treatments for human cancers for which therapies are urgently needed. It mainly designs drugs for which there are existing data suggesting any effect on altered pathways of the cancer cell and may be given safely to humans. The development program of the company includes drugs for the treatment of cancer, consisting of protein phosphatase inhibitors and histone deacetylase inhibitors.
Contact Information
Website
www.lixte.com
Formerly Known As
Srkp 7
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Stock Exchange
NAS
Primary Office
- 680 East Colorado Boulevard
- Suite 180
- Pasadena, CA
- United States
+1 (631) 000-0000
Lixte Biotechnology Holdings Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.36 | $1.35 | $1.11 - $4.79 | $18.6M | 13.7M | 2.24M | -$0.43 |
Lixte Biotechnology Holdings Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 |
|---|---|---|---|---|
| EV | 25,294 | 41,652 | 46,048 | 57,137 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (5,601) | (3,266) | (2,490) | (2,138) |
| Net Income | (5,606) | (3,265) | (2,440) | (2,133) |
| Total Assets | 6,334 | 5,228 | 2,672 | 4,337 |
| Total Debt | 0 | 0 | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Lixte Biotechnology Holdings Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Lixte Biotechnology Holdings‘s full profile, request access.
Request a free trialLixte Biotechnology Holdings Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Lixte Biotech Holdings Inc is a drug discovery company that uses biomarker technology to identify enzyme targets associa
Drug Discovery
Pasadena, CA
4
As of 2020
00.000
00000000
00.000
00000000
derit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupida
0000 000000000
San Diego, CA
000
As of 0000
00000
0000000 0000
00000
0000000
in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat no
0000 000000000
San Diego, CA
00
As of 0000
00000
000000000
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialLixte Biotechnology Holdings Competitors (20)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Biosplice Therapeutics | Private Equity-Backed | San Diego, CA | 000 | 00000 | 0000000 0000 | 00000 |
| 0000000 0000000000 | Formerly VC-backed | San Diego, CA | 00 | 00000 | 000000000 | 00000 |
| 00000 000000000 | Venture Capital-Backed | Cambridge, MA | 00 | 0000 | 00000000000 | 0000 |
| 000000 000 | Formerly VC-backed | Menlo Park, CA | 00 | 00000 | 00000000 | 00000 |
| 0000000 0000000000 | Formerly VC-backed | Boston, MA | 00 | 00000 | 00000000 | 00000 |
Lixte Biotechnology Holdings Executive Team (4)
Lixte Biotechnology Holdings Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000 000000000000 | Lixte Biotechnology Holdings | Board Member | 000 0000 |
| 0000 000000 00 | Lixte Biotechnology Holdings | Chief Executive Officer & Chairman | 000 0000 |
Lixte Biotechnology Holdings Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialLixte Biotechnology Holdings Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 0000000 | 08-Jun-2006 | 0000000000 | Biotechnology | 0000 0000 |